1. Home
  2. ANGH vs BNGO Comparison

ANGH vs BNGO Comparison

Compare ANGH & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Anghami Inc.

ANGH

Anghami Inc.

HOLD

Current Price

$2.35

Market Cap

22.1M

ML Signal

HOLD

Logo Bionano Genomics Inc.

BNGO

Bionano Genomics Inc.

HOLD

Current Price

$1.10

Market Cap

24.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANGH
BNGO
Founded
2012
2003
Country
United Arab Emirates
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
22.1M
24.3M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
ANGH
BNGO
Price
$2.35
$1.10
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$6.33
AVG Volume (30 Days)
19.7K
306.6K
Earning Date
04-30-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$96,736,848.00
$28,720,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$24.27
P/E Ratio
N/A
N/A
Revenue Growth
85.06
N/A
52 Week Low
$2.25
$1.06
52 Week High
$7.60
$6.32

Technical Indicators

Market Signals
Indicator
ANGH
BNGO
Relative Strength Index (RSI) 36.43 25.58
Support Level $2.29 $1.07
Resistance Level $2.44 $1.23
Average True Range (ATR) 0.18 0.10
MACD -0.04 -0.02
Stochastic Oscillator 7.90 5.19

Price Performance

Historical Comparison
ANGH
BNGO

About ANGH Anghami Inc.

Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with a catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner Music. It generates the majority of its revenue from subscriptions.

About BNGO Bionano Genomics Inc.

Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in Americas, EMEA and Asia Pacific; majority revenue being generated from Americas. They generate product revenue from sales of its OGM and Ionic Purification systems and consumables, which includes its instruments, and their VIA software.

Share on Social Networks: